华芢生物-B(02396.HK)：Pro-101-2治疗糖尿病足溃疡的II期临床试验完成全部患者入组

智通财经07-13

【华芢生物-B(02396.HK)：Pro-101-2治疗糖尿病足溃疡的II期临床试验完成全部患者入组】智通财经APP讯，华芢生物-B(02396.HK)发布公告，公司研发并用于治疗糖尿病足溃疡的Pro-101-2的II期临床试验，于近日完成了全部患者入组。 Pro-101-2为本公司核心产品之一。本临床试验为一项随机、双盲、安慰剂对照研究，旨在进一步评价重组人血小板源生长因数(rhPDGF-...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2651001119?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-07-13 20:14","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2651001119","market":"hk","top_or_hot":-1,"title":"华芢生物-B(02396.HK)：Pro-101-2治疗糖尿病足溃疡的II期临床试验完成全部患者入组","media":"智通财经","content":"<div>\n<p>【华芢生物-B(02396.HK)：Pro-101-2治疗糖尿病足溃疡的II期临床试验完成全部患者入组】智通财经APP讯，华芢生物-B(02396.HK)发布公告，公司研发并用于治疗糖尿病足溃疡的Pro-101-2的II期临床试验，于近日完成了全部患者入组。 \n\nPro-101-2为本公司核心产品之一。本临床试验为一项随机、双盲、安慰剂对照研究，旨在进一步评价重组人血小板源生长因数(rhPDGF-...</p>\n\n<a href=\"https://www.zhitongcaijing.com/immediately.html?type=ganggu\">网页链接</a>\n\n</div>\n","source":"live_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>华芢生物-B(02396.HK)：Pro-101-2治疗糖尿病足溃疡的II期临床试验完成全部患者入组</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n华芢生物-B(02396.HK)：Pro-101-2治疗糖尿病足溃疡的II期临床试验完成全部患者入组\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-13 20:14 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.zhitongcaijing.com/immediately.html?type=ganggu><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>【华芢生物-B(02396.HK)：Pro-101-2治疗糖尿病足溃疡的II期临床试验完成全部患者入组】智通财经APP讯，华芢生物-B(02396.HK)发布公告，公司研发并用于治疗糖尿病足溃疡的Pro-101-2的II期临床试验，于近日完成了全部患者入组。 \n\nPro-101-2为本公司核心产品之一。本临床试验为一项随机、双盲、安慰剂对照研究，旨在进一步评价重组人血小板源生长因数(rhPDGF-...</p>\n\n<a href=\"https://www.zhitongcaijing.com/immediately.html?type=ganggu\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02396","symbol_name":"华芢生物-B","start_time":0,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","article_id":"2651001119","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2651001119","pubTimestamp":1783944869,"columns":[],"sourceInfo":{"source_id":"live_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"【华芢生物-B(02396.HK)：Pro-101-2治疗糖尿病足溃疡的II期临床试验完成全部患者入组】智通财经APP讯，华芢生物-B(02396.HK)发布公告，公司研发并用于治疗糖尿病足溃疡的Pr","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02396":"华芢生物-B","BK1161":"生物科技"},"translate_title":"Hua Bio-B (02396.HK): Phase II clinical trial of Pro-101-2 for the treatment of diabetic foot ulcer completed all patient enrollment","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02396":1.5},"content_text":"【华芢生物-B(02396.HK)：Pro-101-2治疗糖尿病足溃疡的II期临床试验完成全部患者入组】智通财经APP讯，华芢生物-B(02396.HK)发布公告，公司研发并用于治疗糖尿病足溃疡的Pro-101-2的II期临床试验，于近日完成了全部患者入组。 \n\nPro-101-2为本公司核心产品之一。本临床试验为一项随机、双盲、安慰剂对照研究，旨在进一步评价重组人血小板源生长因数(rhPDGF-BB)凝胶治疗糖尿病足溃疡的有效性和安全性，并在大量入组受试者中为后续III期临床试验的设计提供关键参数。此次Pro-101-2的II期临床试验完成患者入组是公司在糖尿病足溃疡治疗领域上的又一次重大的研发进展。","kind":"live","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2651001119","isCrawlerRequest":true}